Your browser doesn't support javascript.
loading
Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease.
Bruno, Tiziana; Catena, Valeria; Corleone, Giacomo; Cortile, Clelia; Cappelletto, Maria Chiara; Bellei, Barbara; De Nicola, Francesca; Amadio, Bruno; Gumenyuk, Svitlana; Marchesi, Francesco; Annibali, Ombretta; Blandino, Giovanni; Fanciulli, Maurizio; Di Agostino, Silvia.
Afiliación
  • Bruno T; SAFU Laboratory, Department of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Catena V; SAFU Laboratory, Department of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Corleone G; SAFU Laboratory, Department of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Cortile C; SAFU Laboratory, Department of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Cappelletto MC; Microbiology and Virology Unit, San Gallicano Dermatological Institute IRCCS, Rome, Italy.
  • Bellei B; Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, IRCCS San Gallicano Dermatological Institute, Rome, Italy.
  • De Nicola F; SAFU Laboratory, Department of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Amadio B; SAFU Laboratory, Department of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Gumenyuk S; Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Marchesi F; Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Annibali O; Unit Of Hematology, Stem Cell Transplantation, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128, Roma, Italy.
  • Blandino G; Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53, 00144, Rome, Italy.
  • Fanciulli M; SAFU Laboratory, Department of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy. maurizio.fanciulli@ifo.it.
  • Di Agostino S; Department of Health Sciences, Magna Græcia University of Catanzaro, 88100, Catanzaro, Italy.
Leukemia ; 38(4): 877-882, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38368441
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: MicroARNs / Mieloma Múltiple Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: MicroARNs / Mieloma Múltiple Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Italia